Letter to the editor regarding the paper by A. Lozano-Blázquez et al. Differences in cancer drug assessment between Spain and the United Kingdom.
Pharmacy and Medicines Department, Servei Català de la Salut (CatSalut), Barcelona, Spain. Electronic address: aprat@catsalut.cat.
Alba
A
Prat
Pharmacy and Medicines Department, Servei Català de la Salut (CatSalut), Barcelona, Spain.
Antoni
A
Gilabert
Pharmacy and Medicines Department, Servei Català de la Salut (CatSalut), Barcelona, Spain. Electronic address: ruth.puig@catsalut.cat.
Ruth
R
Puig-Peiro
Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Anna
A
Feliu
Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Mireia
M
Riba
Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Maria Antonia
MA
Mangues
Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Josep
J
Tabernero
D000970:Antineoplastic Agents; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms; D013030:Spain; D006113:United Kingdom
D000970:Antineoplastic Agents